When an insurance denial blocks guest writer Denise Schnieders from getting an MS disease activity test, she decides to fight back.
The monoclonal antibody ublituximab enhances antibody-dependent cellular cytolysis and produces B-cell depletion. Ublituximab is being evaluated for the treatment of relapsing multiple sclerosis. In ...
Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results